Raymond James Financial’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
142,529
-9,857
-6% -$226K ﹤0.01% 3212
2026
Q1
$3.36M Sell
152,386
-84,295
-36% -$1.47M ﹤0.01% 2927
2025
Q4
$2.79M Sell
236,681
-77,354
-25% -$993K ﹤0.01% 3002
2025
Q3
$4.97M Buy
314,035
+63,063
+25% +$915K ﹤0.01% 2453
2025
Q2
$2.87M Buy
250,972
+86,876
+53% +$979K ﹤0.01% 2791
2025
Q1
$2.22M Buy
164,096
+28,986
+21% +$481K ﹤0.01% 2912
2024
Q4
$2.28M Buy
+135,110
New +$2.63M ﹤0.01% 2870

Other funds holding CC

Raymond James Financial's CC Position: Q2 2026 in Review

Raymond James Financial reduced its Chemours (CC) stake by 6.5% in Q2 2026, selling an estimated $226K and leaving 142,529 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

Raymond James Financial first reported a position in CC in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.97M in Q3 2025. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Raymond James Financial held 142,529 shares of Chemours worth $2.92M as of Q2 2026.
  • Raymond James Financial sold 9,857 Chemours shares in Q2 2026, an estimated $226K.
  • Chemours made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3212 holding.
  • Raymond James Financial first reported a position in Chemours in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Chemours position peaked at $4.97M in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.